BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22722464)

  • 1. Microcystic adnexal carcinoma versus desmoplastic trichoepithelioma: a comparative study.
    Tse JY; Nguyen AT; Le LP; Hoang MP
    Am J Dermatopathol; 2013 Feb; 35(1):50-5. PubMed ID: 22722464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
    Sellheyer K; Nelson P; Kutzner H; Patel RM
    J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
    Jedrych J; McNiff JM
    Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?
    Mohanty SK; Sardana R; McFall M; Pradhan D; Usmani A; Jha S; Mishra SK; Sampat NY; Lobo A; Wu JM; Balzer BL; Frishberg DP
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):273-277. PubMed ID: 35384877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
    Evangelista MT; North JP
    J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ln-γ 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms.
    Koga K; Anan T; Fukumoto T; Fujimoto M; Nabeshima K
    Histopathology; 2020 Jan; 76(2):318-324. PubMed ID: 31429981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
    Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
    Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
    Bartoš V
    Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors.
    Wick MR; Cooper PH; Swanson PE; Kaye VN; Sun TT
    Arch Dermatol; 1990 Feb; 126(2):189-94. PubMed ID: 1689137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery.
    Merritt BG; Snow SN; Longley BJ
    Cutis; 2010 May; 85(5):254-8. PubMed ID: 20540416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
    Mitcov M; Scrivener Y; Cribier B
    Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
    Smith KJ; Williams J; Corbett D; Skelton H
    Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcystic Adnexal Carcinoma and a Summary of Other Rare Malignant Adnexal Tumours.
    Aslam A
    Curr Treat Options Oncol; 2017 Aug; 18(8):49. PubMed ID: 28681209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microcystic adnexal carcinoma: a case report with immunohistochemical and electron microscopical examinations.
    Kato N; Yasuoka A; Ueno H
    J Dermatol; 1992 Jan; 19(1):51-7. PubMed ID: 1593021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p63 Immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors.
    Vidal CI; Goldberg M; Burstein DE; Emanuel HJ; Emanuel PO
    Am J Dermatopathol; 2010 May; 32(3):257-261. PubMed ID: 20098297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
    Katona TM; Perkins SM; Billings SD
    J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merkel cells and sclerosing epithelial neoplasms.
    Abesamis-Cubillan E; El-Shabrawi-Caelen L; LeBoit PE
    Am J Dermatopathol; 2000 Aug; 22(4):311-5. PubMed ID: 10949455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid carcinoma revisited: a possible variant of microcystic adnexal carcinoma.
    Lai JH; Limacher JJ; Richards RN
    Am J Dermatopathol; 2014 Nov; 36(11):925-7. PubMed ID: 25343214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmoplastic trichoepithelioma with perineural involvement: a series of seven cases.
    Jedrych J; Leffell D; McNiff JM
    J Cutan Pathol; 2012 Mar; 39(3):317-23. PubMed ID: 22335590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collision tumor of microcystic adnexal carcinoma and squamous cell carcinoma discovered on Mohs sections.
    Ken KM; Moye MS; Vandergriff T; Nijhawan RI
    JAAD Case Rep; 2020 Jun; 6(6):479-481. PubMed ID: 32490104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.